Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.87% | 68.65% | 90.70% | 70.43% | 36.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.87% | 68.65% | 90.70% | 70.43% | 36.07% |
| Cost of Revenue | 117.01% | 78.08% | 98.77% | 74.91% | 22.82% |
| Gross Profit | 32.21% | 64.41% | 87.25% | 68.48% | 42.39% |
| SG&A Expenses | 28.27% | 31.10% | 26.65% | 19.19% | 18.04% |
| Depreciation & Amortization | -55.14% | -52.82% | -40.68% | -28.86% | 30.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.33% | 34.71% | 36.36% | 27.53% | 20.36% |
| Operating Income | 70.48% | 169.20% | 148.92% | 118.90% | 38.89% |
| Income Before Tax | -36.23% | 64.62% | 56.83% | 43.31% | 51.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.23% | 64.62% | 56.83% | 43.31% | 51.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.23% | 64.62% | 56.83% | 43.31% | 50.89% |
| EBIT | 70.48% | 169.20% | 148.92% | 118.90% | 38.89% |
| EBITDA | 436.66% | 572.38% | 262.95% | 210.33% | 89.73% |
| EPS Basic | -35.75% | 64.84% | 57.05% | 43.58% | 51.14% |
| Normalized Basic EPS | 1.11% | 52.60% | 42.03% | 23.12% | -2.45% |
| EPS Diluted | -35.75% | 64.84% | 57.05% | 43.58% | 51.14% |
| Normalized Diluted EPS | 1.11% | 52.60% | 42.03% | 23.12% | -2.45% |
| Average Basic Shares Outstanding | 0.35% | 0.54% | 0.55% | 0.56% | 0.67% |
| Average Diluted Shares Outstanding | 0.35% | 0.54% | 0.55% | 0.56% | 0.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |